Insights on Supply Chain Risk Management
Criterion Consulting’s expertise helps pharmaceutical supply chain management with exceptions handling and achieving DSCSA compliance.
Pharmacies Must Do Away with Inference.
Now Is the Time to Prepare for DSCSA Compliance.
By Matt Campasano, Principal Consultant, Criterion Consulting
Pharmacies that act now to implement real-time, one-to-one verification supported by experienced partners can protect patients, preserve operational flow, and remain compliant with both the letter and spirit of the law.
2025 DSCSA Deadlines Are Approaching — Is Your Team Ready?
By Matt Campasano, Principal Consultant, Criterion Consulting
Free Download:
DSCSA Compliance FAQ
Gain clarity on key Drug Supply Chain Security Act (DSCSA) requirements with our free FAQ guide.
Industry Contributions
Matt Campasano on Why Investigator Is a Game-Changer for Exception Management
LSPedia
Matt Campasano breaks down the real-world difference LSPedia’s Investigator makes for supply chain teams. From faster resolution times to standardized exception data…
Will FDA Finally Enforce DSCSA Interoperability In 2025?
Biopress Online
Few pharma supply chain stories from 2024 stand out like the drama surrounding the Drug Supply Chain Security Act’s second enforcement extension…
Data Quality Issues At The Heart Of FDA's DSCSA Troubles
Biopress Online
With the FDA’s newly extended Drug Supply Chain Security Act (DSCSA) deadlines for 2025, pharmaceutical supply chain partners now have additional time to meet compliance requirements…
An Overview of RFID Within the Pharmaceutical Industry
Pharmaceutical Commerce
In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing why the pharma supply chain sees value in this technology and why its use has fluctuated over the past decade.
Read more of Criterion’s and Matt Campasano’s pharma logistics and supply chain compliance expertise in recent media.